Titlebook: Analgesia; Christoph Stein Book 2007 Springer-Verlag Berlin Heidelberg 2007 Arthritis.Cancer.Cannabinoid.Headache.Inflammation.Opioid.Pain

lexicographer

書目名稱Analgesia影響因子(影響力)




書目名稱Analgesia影響因子(影響力)學(xué)科排名




書目名稱Analgesia網(wǎng)絡(luò)公開度




書目名稱Analgesia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Analgesia被引頻次




書目名稱Analgesia被引頻次學(xué)科排名




書目名稱Analgesia年度引用




書目名稱Analgesia年度引用學(xué)科排名




書目名稱Analgesia讀者反饋




書目名稱Analgesia讀者反饋學(xué)科排名

capsule

使熄滅

https://doi.org/10.1007/978-3-662-33072-2kinins have a pathophysiological role in nociception. Clinical studies with non-peptide pharmacological antagonists are now in progress to determine if blocking the action of these peptides might have utility in the treatment of pain.

GROUP

https://doi.org/10.1007/978-3-642-97695-7of P2X. receptors may be useful for relieving inflammatory and neuropathic pain. More recently, data have begun to emerge implicating P2X., P2X. and P2Y receptors in aspects of pain transmission. Both P1 and P2 receptors may represent novel targets for pain relief.

insurrection

乳白光

Neuropeptide and Kinin Antagonistskinins have a pathophysiological role in nociception. Clinical studies with non-peptide pharmacological antagonists are now in progress to determine if blocking the action of these peptides might have utility in the treatment of pain.

阻擋

Adenosine and ATP Receptorsof P2X. receptors may be useful for relieving inflammatory and neuropathic pain. More recently, data have begun to emerge implicating P2X., P2X. and P2Y receptors in aspects of pain transmission. Both P1 and P2 receptors may represent novel targets for pain relief.

figurine

Opioidsg, cAMP inhibition, Ca. channel inhibition) have been described. The differential regulation of effectors, preclinical pharmacology, clinical applications, and side effects will be reviewed in this chapter.

Eructation

Antipyretic Analgesics: Nonsteroidal Antiinflammatory Drugs, Selective COX-2 Inhibitors, Paracetamolese drugs with particular emphasis on their rational use based on the diverse pharmacokinetic characteristics and adverse drug reaction profiles. Referring to the current debate, potential mechanisms underlying cardiovascular side effects associated with long-term use of COX inhibitors are discussed.

cardiac-arrest